BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008;54:1696-1704. [PMID: 18719201 DOI: 10.1373/clinchem.2007.101741] [Cited by in Crossref: 316] [Cited by in F6Publishing: 289] [Article Influence: 22.6] [Reference Citation Analysis]
Number Citing Articles
1 Sheervalilou R, Ansarin K, Fekri Aval S, Shirvaliloo S, Pilehvar-Soltanahmadi Y, Mohammadian M, Zarghami N. An update on sputum MicroRNAs in lung cancer diagnosis. Diagn Cytopathol 2016;44:442-9. [PMID: 26865409 DOI: 10.1002/dc.23444] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
2 Witten D, Tibshirani R, Gu SG, Fire A, Lui WO. Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010;8:58. [PMID: 20459774 DOI: 10.1186/1741-7007-8-58] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 9.7] [Reference Citation Analysis]
3 Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest. 2010;120:1298-1309. [PMID: 20237410 DOI: 10.1172/jci39566.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther 2012;12:1221-39. [PMID: 22731874 DOI: 10.1517/14712598.2012.697149] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
5 Zhao Y, Chen X, Yin J, Valencia A. Adaptive boosting-based computational model for predicting potential miRNA-disease associations. Bioinformatics 2019;35:4730-8. [DOI: 10.1093/bioinformatics/btz297] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
6 Liu K, Li G, Fan C, Zhou X, Wu B, Li J. Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer. J Int Med Res 2011;39:2288-95. [PMID: 22289545 DOI: 10.1177/147323001103900626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci. 2015;22:9. [PMID: 25614041 DOI: 10.1186/s12929-015-0113-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 11.9] [Reference Citation Analysis]
8 Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2010;10:297-308. [PMID: 20370587 DOI: 10.1586/erm.10.11] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 14.7] [Reference Citation Analysis]
9 Tanaka T, Tanaka M, Tanaka T, Ishigamori R. Biomarkers for colorectal cancer. Int J Mol Sci. 2010;11:3209-3225. [PMID: 20957089 DOI: 10.3390/ijms11093209] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
10 Shaker O, Maher M, Nassar Y, Morcos G, Gad Z. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. Gene 2015;560:77-82. [PMID: 25644077 DOI: 10.1016/j.gene.2015.01.062] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
11 Chira P, Vareli K, Sainis I, Papandreou C, Briasoulis E. Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value. Cancers (Basel) 2010;2:1328-53. [PMID: 24281118 DOI: 10.3390/cancers2021328] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
12 Markou A, Zavridou M, Sourvinou I, Yousef G, Kounelis S, Malamos N, Georgoulias V, Lianidou E. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients. Clinical Chemistry 2016;62:1002-11. [DOI: 10.1373/clinchem.2015.253716] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
13 Salamo O, Mortaz E, Mirsaeidi M. Noncoding RNAs: New Players in Pulmonary Medicine and Sarcoidosis. Am J Respir Cell Mol Biol 2018;58:147-56. [DOI: 10.1165/rcmb.2017-0196tr] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Wang J, Raimondo M, Guha S, Chen J, Diao L, Dong X, Wallace MB, Killary AM, Frazier ML, Woodward TA, Wang J, Sen S. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. J Cancer. 2014;5:696-705. [PMID: 25258651 DOI: 10.7150/jca.10094] [Cited by in Crossref: 62] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
15 Marin I, Ofek E, Bar J, Prisant N, Perelman M, Avivi C, Lavy-Shahaf G, Onn A, Katz R, Barshack I. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study. J Clin Pathol 2020;73:636-41. [PMID: 32060074 DOI: 10.1136/jclinpath-2019-206420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Zhang Y, Yan Y, Chen W, Cheng W, Li S, Ding X, Li D, Wang H, Ju H, Ding S. A simple electrochemical biosensor for highly sensitive and specific detection of microRNA based on mismatched catalytic hairpin assembly. Biosensors and Bioelectronics 2015;68:343-9. [DOI: 10.1016/j.bios.2015.01.026] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 14.3] [Reference Citation Analysis]
17 Wang M, Shen B, Yuan R, Cheng W, Xu H, Ding S. An electrochemical biosensor for highly sensitive determination of microRNA based on enzymatic and molecular beacon mediated strand displacement amplification. Journal of Electroanalytical Chemistry 2015;756:147-52. [DOI: 10.1016/j.jelechem.2015.08.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
18 Chi BZ, Liang RP, Qiu WB, Yuan YH, Qiu JD. Direct fluorescence detection of microRNA based on enzymatically engineered primer extension poly-thymine (EPEPT) reaction using copper nanoparticles as nano-dye. Biosens Bioelectron 2017;87:216-21. [PMID: 27566394 DOI: 10.1016/j.bios.2016.08.042] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
19 Du W, Tang H, Lei Z, Zhu J, Zeng Y, Liu Z, Huang JA. miR-335-5p inhibits TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1. Respir Res 2019;20:225. [PMID: 31638991 DOI: 10.1186/s12931-019-1184-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
20 Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31:37-49. [PMID: 19955394 DOI: 10.1093/carcin/bgp272] [Cited by in Crossref: 398] [Cited by in F6Publishing: 384] [Article Influence: 30.6] [Reference Citation Analysis]
21 Sempere LF. Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn 2011;11:813-27. [PMID: 22022944 DOI: 10.1586/erm.11.69] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
22 Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl). 2010;88:709-717. [PMID: 20349219 DOI: 10.1007/s00109-010-0617-2]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010;120:1298-309. [PMID: 20237410 DOI: 10.1172/JCI39566] [Cited by in Crossref: 290] [Cited by in F6Publishing: 182] [Article Influence: 24.2] [Reference Citation Analysis]
24 Zheng X, Dong L, Zhao S, Li Q, Liu D, Zhu X, Ge X, Li R, Wang G. Propofol Affects Non-Small-Cell Lung Cancer Cell Biology By Regulating the miR-21/PTEN/AKT Pathway In Vitro and In Vivo. Anesth Analg 2020;131:1270-80. [PMID: 32925348 DOI: 10.1213/ANE.0000000000004778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
25 Seven M, Karatas OF, Duz MB, Ozen M. The role of miRNAs in cancer: from pathogenesis to therapeutic implications. Future Oncology 2014;10:1027-48. [DOI: 10.2217/fon.13.259] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
26 Yang J, Tang M, Diao W, Cheng W, Zhang Y, Yan Y. Electrochemical strategy for ultrasensitive detection of microRNA based on MNAzyme-mediated rolling circle amplification on a gold electrode. Microchim Acta 2016;183:3061-7. [DOI: 10.1007/s00604-016-1958-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
27 Qi J, Mu D. MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med 2012;6:134-55. [PMID: 22528868 DOI: 10.1007/s11684-012-0188-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
28 Jiang Q, Hao Y, Wang G, Juan L, Zhang T, Teng M, Liu Y, Wang Y. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol 2010;4 Suppl 1:S2. [PMID: 20522252 DOI: 10.1186/1752-0509-4-S1-S2] [Cited by in Crossref: 228] [Cited by in F6Publishing: 138] [Article Influence: 19.0] [Reference Citation Analysis]
29 Tian L, Qi J, Oderinde O, Yao C, Song W, Wang Y. Planar intercalated copper (II) complex molecule as small molecule enzyme mimic combined with Fe3O4 nanozyme for bienzyme synergistic catalysis applied to the microRNA biosensor. Biosensors and Bioelectronics 2018;110:110-7. [DOI: 10.1016/j.bios.2018.03.045] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
30 Shen Y, Wang T, Yang T, Hu Q, Wan C, Chen L, Wen F. Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis. Genet Test Mol Biomarkers 2013;17:359-66. [PMID: 23387316 DOI: 10.1089/gtmb.2012.0370] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
31 Liao Y, Huang R, Ma Z, Wu Y, Zhou X, Xing D. Target-Triggered Enzyme-Free Amplification Strategy for Sensitive Detection of MicroRNA in Tumor Cells and Tissues. Anal Chem 2014;86:4596-604. [DOI: 10.1021/ac5007427] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 13.8] [Reference Citation Analysis]
32 Alinovi R, Goldoni M, Pinelli S, Ravanetti F, Galetti M, Pelosi G, De Palma G, Apostoli P, Cacchioli A, Mutti A, Mozzoni P. Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles. Toxicol In Vitro 2017;42:76-85. [PMID: 28400205 DOI: 10.1016/j.tiv.2017.04.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
33 Chen X, Yan GY. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep 2014;4:5501. [PMID: 24975600 DOI: 10.1038/srep05501] [Cited by in Crossref: 213] [Cited by in F6Publishing: 195] [Article Influence: 26.6] [Reference Citation Analysis]
34 Gao W, Lu X, Liu L, Xu J, Feng D, Shu Y. MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther. 2012;13:330-340. [PMID: 22237007 DOI: 10.4161/cbt.19073] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 9.5] [Reference Citation Analysis]
35 Rosell R, Wei J, Taron M. Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2009;10:8-9. [PMID: 19289365 DOI: 10.3816/clc.2009.n.001] [Cited by in Crossref: 89] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
36 Duncavage E, Goodgame B, Sezhiyan A, Govindan R, Pfeifer J. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer. J Thorac Oncol 2010;5:1755-63. [PMID: 20975375 DOI: 10.1097/JTO.0b013e3181f3909d] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
37 Van Den Broeck A, Ozenne P, Eymin B, Gazzeri S. Lung cancer: a modified epigenome. Cell Adh Migr 2010;4:107-13. [PMID: 20139698 DOI: 10.4161/cam.4.1.10885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lee HW, Ha SY, Roh MS. Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors. Korean J Pathol 2014;48:17-23. [PMID: 24627690 DOI: 10.4132/KoreanJPathol.2014.48.1.17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Li G, Xie J, Wang J. Tumor suppressor function of miR-129-5p in lung cancer. Oncol Lett 2019;17:5777-83. [PMID: 31186804 DOI: 10.3892/ol.2019.10241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
40 Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J. 2012;18:244-252. [PMID: 22647361 DOI: 10.1097/ppo.0b013e318258b78f] [Cited by in Crossref: 170] [Cited by in F6Publishing: 102] [Article Influence: 17.0] [Reference Citation Analysis]
41 Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2012;29:618-626. [PMID: 21516486 DOI: 10.1007/s12032-011-9923-y] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 14.7] [Reference Citation Analysis]
42 Liu ZL, Wang H, Liu J, Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem. 2013;372:35-45. [PMID: 22956424 DOI: 10.1007/s11010-012-1443-3] [Cited by in Crossref: 200] [Cited by in F6Publishing: 208] [Article Influence: 20.0] [Reference Citation Analysis]
43 Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, Harris CC. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 2011;17:1875-82. [PMID: 21350005 DOI: 10.1158/1078-0432.CCR-10-2961] [Cited by in Crossref: 143] [Cited by in F6Publishing: 82] [Article Influence: 13.0] [Reference Citation Analysis]
44 Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl). 2010;88:709-717. [PMID: 20349219 DOI: 10.1007/s00109-010-0617-2] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
45 Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703-740. [PMID: 22054881 DOI: 10.1016/j.ccm.2011.08.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
46 Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537-561. [PMID: 21532838 DOI: 10.2174/138920210793175895] [Cited by in Crossref: 815] [Cited by in F6Publishing: 771] [Article Influence: 74.1] [Reference Citation Analysis]
47 White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol. 2011;8:75-84. [PMID: 21045789 DOI: 10.1038/nrclinonc.2010.173] [Cited by in Crossref: 136] [Cited by in F6Publishing: 134] [Article Influence: 11.3] [Reference Citation Analysis]
48 Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol. 2013;30:376. [PMID: 23277281 DOI: 10.1007/s12032-012-0376-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
49 Hulf T, Sibbritt T, Wiklund ED, Patterson K, Song JZ, Stirzaker C, Qu W, Nair S, Horvath LG, Armstrong NJ, Kench JG, Sutherland RL, Clark SJ. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. Oncogene 2013;32:2891-9. [PMID: 22869146 DOI: 10.1038/onc.2012.300] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
50 Wang B, Yu J, Sun Z, Luh F, Lin D, Shen Y, Wang T, Zhang Q, Liu X. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer. Mol Carcinog 2020;59:908-22. [PMID: 32346924 DOI: 10.1002/mc.23203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zhu D, Liu W, Cao W, Chao J, Su S, Wang L, Fan C. Multiple Amplified Electrochemical Detection of MicroRNA-21 Using Hierarchical Flower-like Gold Nanostructures Combined with Gold-enriched Hybridization Chain Reaction. Electroanalysis 2018;30:1349-56. [DOI: 10.1002/elan.201700696] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
52 Yu H, Chen X, Lu L. Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm. Sci Rep 2017;7:43792. [PMID: 28317855 DOI: 10.1038/srep43792] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
53 Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications. Genet Res Int 2012;2012:737416. [PMID: 22852089 DOI: 10.1155/2012/737416] [Cited by in Crossref: 23] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
54 Wang K, Chen M, Wu W. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. World J Surg Oncol 2017;15:175. [PMID: 28927412 DOI: 10.1186/s12957-017-1244-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
55 Jiang L, Lv X, Li J, Li J, Li X, Li W, Li Y. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta Histochemica 2012;114:582-8. [DOI: 10.1016/j.acthis.2011.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
56 Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J, Chen L. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma. J Thorac Cardiovasc Surg 2015;149:1404-14.e4. [PMID: 25813410 DOI: 10.1016/j.jtcvs.2015.02.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
57 Pop-Bica C, Pintea S, Magdo L, Cojocneanu R, Gulei D, Ferracin M, Berindan-Neagoe I. The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis. Front Oncol 2020;10:516850. [PMID: 33194579 DOI: 10.3389/fonc.2020.516850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, Dunant A, Pham TC, Petrini I, Lee A, Khan MA, Hainaut P, Pignon JP, Brambilla E, Popper HH, Filipits M, Harris CC, Giaccone G. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res 2010;70:8288-98. [PMID: 20978195 DOI: 10.1158/0008-5472.CAN-10-1348] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
59 Zhang W, Bai W, Zhang W. MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells. Clin Transl Oncol. 2014;16:708-713. [PMID: 24293118 DOI: 10.1007/s12094-013-1135-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
60 Zhu W, Xu B. MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis. PLoS One. 2014;9:e103373. [PMID: 25098165 DOI: 10.1371/journal.pone.0103373] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
61 Peng L, Zhou J, Liang Z, Zhang Y, Petti L, Jiang T, Gu C, Yang D, Mormile P. SERS-based sandwich bioassay protocol of miRNA-21 using Au@Ag core–shell nanoparticles and a Ag/TiO 2 nanowires substrate. Anal Methods 2019;11:2960-8. [DOI: 10.1039/c9ay00573k] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
62 Chen X, Cheng JY, Yin J. Predicting microRNA-disease associations using bipartite local models and hubness-aware regression. RNA Biol 2018;15:1192-205. [PMID: 30196756 DOI: 10.1080/15476286.2018.1517010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
63 Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer. 2013;81:388-396. [PMID: 23756108 DOI: 10.1016/j.lungcan.2013.05.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 133] [Article Influence: 15.4] [Reference Citation Analysis]
64 Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Genomic medicine in non-small cell lung cancer: paving the path to personalized care. Respirology 2011;16:257-63. [PMID: 21044232 DOI: 10.1111/j.1440-1843.2010.01892.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
65 Kim H, Yang JM, Jin Y, Jheon S, Kim K, Lee CT, Chung JH, Paik JH. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status. Oncotarget 2017;8:8484-98. [PMID: 28035073 DOI: 10.18632/oncotarget.14298] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
66 Azzouzi S, Mak WC, Kor K, Turner AP, Ali MB, Beni V. An integrated dual functional recognition/amplification bio-label for the one-step impedimetric detection of Micro-RNA-21. Biosensors and Bioelectronics 2017;92:154-61. [DOI: 10.1016/j.bios.2017.02.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
67 Janiszewska J, Szaumkessel M, Szyfter K. microRNAs are important players in head and neck carcinoma: a review. Crit Rev Oncol Hematol 2013;88:716-28. [PMID: 23948550 DOI: 10.1016/j.critrevonc.2013.07.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
68 Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, Cstoth I, Dernies T, Toussaint L, Leclercq N, Sculier JP; European Lung Cancer Working Party. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 2013;82:340-5. [PMID: 24007627 DOI: 10.1016/j.lungcan.2013.07.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
69 Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One. 2012;7:e41629. [PMID: 22860003 DOI: 10.1371/journal.pone.0041629] [Cited by in Crossref: 141] [Cited by in F6Publishing: 150] [Article Influence: 14.1] [Reference Citation Analysis]
70 Liu J, Zhu H, Yang X, Ge Y, Zhang C, Qin Q, Lu J, Zhan L, Cheng H, Sun X. MicroRNA-21 is a novel promising target in cancer radiation therapy. Tumour Biol 2014;35:3975-9. [PMID: 24446181 DOI: 10.1007/s13277-014-1623-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
71 Ishikawa H, Yamada H, Taromaru N, Kondo K, Nagura A, Yamazaki M, Ando Y, Munetsuna E, Suzuki K, Ohashi K, Teradaira R. Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions. Ann Clin Biochem. 2017;54:134-142. [PMID: 27166305 DOI: 10.1177/0004563216647086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
72 Michailidi C, Hayashi M, Datta S, Sen T, Zenner K, Oladeru O, Brait M, Izumchenko E, Baras A, VandenBussche C, Argos M, Bivalacqua TJ, Ahsan H, Hahn NM, Netto GJ, Sidransky D, Hoque MO. Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. Cancer Prev Res (Phila) 2015;8:208-21. [PMID: 25586904 DOI: 10.1158/1940-6207.CAPR-14-0251] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
73 Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E. Breast cancer and microRNAs: therapeutic impact. Breast 2011;20 Suppl 3:S63-70. [PMID: 22015296 DOI: 10.1016/S0960-9776(11)70297-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
74 Deng D, Liu Z, Du Y. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Adv Genet. 2010;71:125-176. [PMID: 20933128 DOI: 10.1016/b978-0-12-380864-6.00005-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
75 Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Clin Chem. 2014;60:197-205. [PMID: 24132943 DOI: 10.1373/clinchem.2013.210542] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
76 De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97-110. [PMID: 23344542 DOI: 10.1038/nrc3447] [Cited by in Crossref: 1460] [Cited by in F6Publishing: 1424] [Article Influence: 162.2] [Reference Citation Analysis]
77 Wilmott JS, Zhang XD, Hersey P, Scolyer RA. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011;43:657-71. [PMID: 21876471 DOI: 10.1097/PAT.0b013e32834a7358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
78 Duan Y, Chen Q. TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep 2016;36:1837-44. [PMID: 27574009 DOI: 10.3892/or.2016.5023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
79 Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D. Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136-42. [DOI: 10.1002/mc.20712] [Cited by in Crossref: 379] [Cited by in F6Publishing: 373] [Article Influence: 31.6] [Reference Citation Analysis]
80 Li D, Cheng W, Li Y, Xu Y, Li X, Yin Y, Ju H, Ding S. Catalytic Hairpin Assembly Actuated DNA Nanotweezer for Logic Gate Building and Sensitive Enzyme-Free Biosensing of MicroRNAs. Anal Chem 2016;88:7500-6. [PMID: 27367785 DOI: 10.1021/acs.analchem.5b04844] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
81 Junaid M, Dash R, Islam N, Chowdhury J, Alam MJ, Nath SD, Shakil MAS, Azam A, Quader SM, Zahid Hosen SM. Molecular Simulation Studies of 3,3'-Diindolylmethane as a Potent MicroRNA-21 Antagonist. J Pharm Bioallied Sci 2017;9:259-65. [PMID: 29456377 DOI: 10.4103/jpbs.JPBS_266_16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Peralta-Zaragoza O, Deas J, Meneses-Acosta A, De la O-Gómez F, Fernández-Tilapa G, Gómez-Cerón C, Benítez-Boijseauneau O, Burguete-García A, Torres-Poveda K, Bermúdez-Morales VH, Madrid-Marina V, Rodríguez-Dorantes M, Hidalgo-Miranda A, Pérez-Plasencia C. Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells. BMC Cancer 2016;16:215. [PMID: 26975392 DOI: 10.1186/s12885-016-2231-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
83 Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011;108:3713-8. [PMID: 21300873 DOI: 10.1073/pnas.1100048108] [Cited by in Crossref: 488] [Cited by in F6Publishing: 479] [Article Influence: 44.4] [Reference Citation Analysis]
84 Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo D, Yang F, Wei J, Wang L, Dykxhoorn DM, Hare JM, Goldschmidt-Clermont PJ, Dong C. MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ Res 2013;112:152-64. [PMID: 23072816 DOI: 10.1161/CIRCRESAHA.112.280016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
85 Qi Y, Wang X, Kong X, Zhai J, Fang Y, Guan X, Wang J. Expression signatures and roles of microRNAs in inflammatory breast cancer. Cancer Cell Int 2019;19:23. [PMID: 30733644 DOI: 10.1186/s12935-018-0709-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
86 Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N, Watson DI. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol. 2011;18:253-260. [PMID: 20628822 DOI: 10.1245/s10434-010-1213-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
87 Huang Y, Bao T, Li Z, Ji G, Zhang L. Function of miR-200a in proliferation and apoptosis of non-small cell lung cancer cells. Oncol Lett 2020;20:1256-62. [PMID: 32724366 DOI: 10.3892/ol.2020.11649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
88 Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011;104:847-51. [PMID: 21721011 DOI: 10.1002/jso.22008] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 10.1] [Reference Citation Analysis]
89 Hoshino I, Matsubara H. MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Surg Today. 2013;43:467-478. [PMID: 23129027 DOI: 10.1007/s00595-012-0392-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
90 Rothschild SI. microRNA therapies in cancer. Mol Cell Ther. 2014;2:7. [PMID: 26056576 DOI: 10.1186/2052-8426-2-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 9.0] [Reference Citation Analysis]
91 Yang G, Zhang P, Lv A, Liu Y, Wang G. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma. Exp Mol Pathol 2016;100:160-6. [PMID: 26708425 DOI: 10.1016/j.yexmp.2015.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
92 Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. European Journal of Cancer 2010;46:3409-16. [DOI: 10.1016/j.ejca.2010.07.047] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
93 Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B, Liu FF. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 2013;8:e53765. [PMID: 23335975 DOI: 10.1371/journal.pone.0053765] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
94 Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848-5856. [PMID: 19884536 DOI: 10.1200/jco.2009.24.0317] [Cited by in Crossref: 690] [Cited by in F6Publishing: 411] [Article Influence: 53.1] [Reference Citation Analysis]
95 Shen Y, Pan X, Zhao H. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer. Biochem Biophys Res Commun 2014;451:119-25. [PMID: 25065740 DOI: 10.1016/j.bbrc.2014.07.076] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
96 Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS One. 2011;6:e21300. [PMID: 21731696 DOI: 10.1371/journal.pone.0021300] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
97 Chi BZ, Liang RP, Zhang L, Qiu JD. Sensitive and homogeneous microRNA detection using branched cascade enzymatic amplification. Chem Commun (Camb) 2015;51:10543-6. [PMID: 26040236 DOI: 10.1039/c5cc02864g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
98 Greene SB, Herschkowitz JI, Rosen JM. The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol 2010;7:300-4. [PMID: 20436283 DOI: 10.4161/rna.7.3.11837] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
99 Zhou X, Wang X, Huang Z, Wang J, Zhu W, Shu Y, Liu P. Prognostic value of miR-21 in various cancers: an updating meta-analysis. PLoS One 2014;9:e102413. [PMID: 25019505 DOI: 10.1371/journal.pone.0102413] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
100 Zhang L, Wang J, Zhang J, Liu Y, Wu L, Shen J, Zhang Y, Hu Y, Fan Q, Huang W, Wang L. Individual Au-Nanocube Based Plasmonic Nanoprobe for Cancer Relevant MicroRNA Biomarker Detection. ACS Sens 2017;2:1435-40. [PMID: 28840721 DOI: 10.1021/acssensors.7b00322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
101 Liao Q, Han P, Huang Y, Wu Z, Chen Q, Li S, Ye J, Wu X. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis. PLoS One. 2015;10:e0130677. [PMID: 26114756 DOI: 10.1371/journal.pone.0130677] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
102 Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 2012;14:385-92. [PMID: 22580180 DOI: 10.1016/j.jmoldx.2012.02.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
103 Rotunno M, Zhao Y, Bergen AW, Koshiol J, Burdette L, Rubagotti M, Linnoila RI, Marincola FM, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, Wang E, Landi MT. Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. Br J Cancer 2010;103:1870-4. [PMID: 21102586 DOI: 10.1038/sj.bjc.6605976] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
104 Yi J, Chen T, Huo J, Chu X. Nanoscale Zeolitic Imidazolate Framework-8 for Ratiometric Fluorescence Imaging of MicroRNA in Living Cells. Anal Chem 2017;89:12351-9. [DOI: 10.1021/acs.analchem.7b03369] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 15.8] [Reference Citation Analysis]
105 Greene SB, Gunaratne PH, Hammond SM, Rosen JM. A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci. 2010;123:606-618. [PMID: 20103531 DOI: 10.1242/jcs.056812] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
106 Ricciuti B, Mecca C, Crinò L, Baglivo S, Cenci M, Metro G. Non-coding RNAs in lung cancer. Oncoscience 2014;1:674-705. [PMID: 25593996 DOI: 10.18632/oncoscience.98] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
107 Elgamal OA, Park JK, Gusev Y, Azevedo-Pouly AC, Jiang J, Roopra A, Schmittgen TD. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One. 2013;8:e76402. [PMID: 24098490 DOI: 10.1371/journal.pone.0076402] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
108 Fu X, Han Y, Wu Y, Zhu X, Lu X, Mao F, Wang X, He X, Zhao Y, Zhao Y. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest. 2011;41:1245-1253. [PMID: 21521185 DOI: 10.1111/j.1365-2362.2011.02535.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
109 Tran N, O'brien CJ, Clark J, Rose B, Myers JN. Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 2010;32:1099-111. [DOI: 10.1002/hed.21356] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
110 Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, Xu X. Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 2012;92:1084-96. [PMID: 22525428 DOI: 10.1038/labinvest.2012.62] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
111 Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30:2059-63. [PMID: 19901002 DOI: 10.1093/carcin/bgp277] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 9.1] [Reference Citation Analysis]
112 Moore AE, Young LE, Dixon DA. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev. 2011;30:419-435. [PMID: 22005950 DOI: 10.1007/s10555-011-9300-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
113 Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Marsh CB, Otterson GA, Nana-Sinkam SP. MicroRNAs in the pathogenesis of Lung Cancer. J Thorac Oncol 2009;4:1028-34. [PMID: 19474765 DOI: 10.1097/JTO.0b013e3181a99c77] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
114 Singh A, Singh AK, Giri R, Kumar D, Sharma R, Valis M, Kuca K, Garg N. The role of microRNA-21 in the onset and progression of cancer. Future Med Chem 2021;13:1885-906. [PMID: 34590501 DOI: 10.4155/fmc-2021-0096] [Reference Citation Analysis]
115 Castagnino N, Maffei M, Tortolina L, Zoppoli G, Piras D, Nencioni A, Moran E, Ballestrero A, Patrone F, Parodi S. Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial. Wiley Interdiscip Rev Syst Biol Med 2016;8:314-36. [PMID: 27240214 DOI: 10.1002/wsbm.1342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Tian F, Li R, Chen Z, Shen Y, Lu J, Xie X, Ge Q. Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma. Biomed Res Int. 2016;2016:1428271. [PMID: 27247934 DOI: 10.1155/2016/1428271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
117 Rask L, Balslev E, Jørgensen S, Eriksen J, Flyger H, Møller S, Høgdall E, Litman T, Nielsen BS. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 2011;119:663-73. [PMID: 21917003 DOI: 10.1111/j.1600-0463.2011.02782.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
118 Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49:604-615. [PMID: 23099007 DOI: 10.1016/j.ejca.2012.09.031] [Cited by in Crossref: 136] [Cited by in F6Publishing: 145] [Article Influence: 13.6] [Reference Citation Analysis]
119 Kunz M, Göttlich C, Walles T, Nietzer S, Dandekar G, Dandekar T. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact. Tumour Biol 2017;39:101042831770643. [DOI: 10.1177/1010428317706430] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
120 Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18:282-293. [PMID: 20832755 DOI: 10.1016/j.ccr.2010.08.013.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28486. [PMID: 22174818 DOI: 10.1371/journal.pone.0028486] [Cited by in Crossref: 199] [Cited by in F6Publishing: 200] [Article Influence: 18.1] [Reference Citation Analysis]
122 Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer. 2011;104:1168-1177. [PMID: 21407217 DOI: 10.1038/sj.bjc.6606076] [Cited by in Crossref: 189] [Cited by in F6Publishing: 182] [Article Influence: 17.2] [Reference Citation Analysis]
123 Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets. 2012;16 Suppl 2:S103-S109. [PMID: 22443195 DOI: 10.1517/14728222.2011.650632] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
124 Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012;32:326-348. [PMID: 22383180 DOI: 10.1002/med.20215] [Cited by in Crossref: 319] [Cited by in F6Publishing: 303] [Article Influence: 26.6] [Reference Citation Analysis]
125 Jiang L, Chang J, Zhang Q, Sun L, Qiu X. MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells. Cancer Invest 2013;31:538-44. [PMID: 24044511 DOI: 10.3109/07357907.2013.820314] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
126 Salahandish R, Ghaffarinejad A, Omidinia E, Zargartalebi H, Majidzadeh-A K, Naghib SM, Sanati-Nezhad A. Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene. Biosens Bioelectron 2018;120:129-36. [PMID: 30172235 DOI: 10.1016/j.bios.2018.08.025] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
127 Schetter AJ, Harris CC. Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011;38:734-42. [PMID: 22082759 DOI: 10.1053/j.seminoncol.2011.08.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
128 Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2): 48-60 [PMID: 24829851 DOI: 10.5306/wjco.v5.i2.48] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
129 Leidinger P, Keller A, Meese E. MicroRNAs - Important Molecules in Lung Cancer Research. Front Genet 2011;2:104. [PMID: 22303398 DOI: 10.3389/fgene.2011.00104] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
130 Bowman RV, Wright CM, Davidson MR, Francis SM, Yang IA, Fong KM. Epigenomic targets for the treatment of respiratory disease. Expert Opin Ther Targets 2009;13:625-40. [PMID: 19409032 DOI: 10.1517/14728220902926119] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
131 Avci CB, Baran Y. Use of microRNAs in personalized medicine. Methods Mol Biol 2014;1107:311-25. [PMID: 24272446 DOI: 10.1007/978-1-62703-748-8_19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
132 Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol 2016;29:330-46. [PMID: 26916073 DOI: 10.1038/modpathol.2016.38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
133 Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noël A, Martial JA, Struman I. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011;6:e16979. [PMID: 21347332 DOI: 10.1371/journal.pone.0016979] [Cited by in Crossref: 168] [Cited by in F6Publishing: 160] [Article Influence: 15.3] [Reference Citation Analysis]
134 Li S, Kuo HD, Yin R, Wu R, Liu X, Wang L, Hudlikar R, Peter RM, Kong AN. Epigenetics/epigenomics of triterpenoids in cancer prevention and in health. Biochem Pharmacol 2020;175:113890. [PMID: 32119837 DOI: 10.1016/j.bcp.2020.113890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
135 Sempere LF. Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine? Expert Rev Mol Diagn 2014;14:853-69. [PMID: 25090088 DOI: 10.1586/14737159.2014.944507] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
136 Hermansen SK, Dahlrot RH, Nielsen BS, Hansen S, Kristensen BW. MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol 2013;111:71-81. [PMID: 23104517 DOI: 10.1007/s11060-012-0992-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
137 Guo R, Gu J, Zhang Z, Wang Y, Gu C. MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39. Biomed Res Int 2017;2017:2381482. [PMID: 28197410 DOI: 10.1155/2017/2381482] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
138 Nasirian V, Shamsipur M, Molaabasi F, Mansouri K, Sarparast M, Salim V, Barati A, Kashanian S. miRNA-21 rapid diagnosis by one-pot synthesis of highly luminescent red emissive silver nanoclusters/DNA. Sensors and Actuators B: Chemical 2020;308:127673. [DOI: 10.1016/j.snb.2020.127673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
139 Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J. 2012;18:244-252. [PMID: 22647361 DOI: 10.1097/PPO.0b013e318258b78] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Azzouzi S, Fredj Z, Turner APF, Ali MB, Mak WC. Generic Neutravidin Biosensor for Simultaneous Multiplex Detection of MicroRNAs via Electrochemically Encoded Responsive Nanolabels. ACS Sens 2019;4:326-34. [DOI: 10.1021/acssensors.8b00942] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
141 Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009;30:1903-9. [PMID: 19736307 DOI: 10.1093/carcin/bgp219] [Cited by in Crossref: 245] [Cited by in F6Publishing: 238] [Article Influence: 18.8] [Reference Citation Analysis]
142 Tang R, Liang L, Luo D, Feng Z, Huang Q, He R, Gan T, Yang L, Chen G. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer. Med Sci Monit 2015;21:2514-20. [PMID: 26305739 DOI: 10.12659/MSM.894372] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
143 Wang X, Wu M, Liu F, Li Y, Li N, Li G, Shen S. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 2010;345:283-90. [DOI: 10.1007/s11010-010-0582-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
144 Sourvinou IS, Markou A, Lianidou ES. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn. 2013;15:827-834. [PMID: 23988620 DOI: 10.1016/j.jmoldx.2013.07.005] [Cited by in Crossref: 142] [Cited by in F6Publishing: 139] [Article Influence: 15.8] [Reference Citation Analysis]
145 Zhong Z, Wu J, Yuan K, Song Z, Ma Z, Zhong Y, Fang X, Zhang W. Upregulation of microRNA-205 is a potential biomarker for intracranial aneurysms. Neuroreport 2019;30:812-6. [PMID: 31283712 DOI: 10.1097/WNR.0000000000001279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S, Tanaka H. Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett 2012;4:817-23. [PMID: 23205106 DOI: 10.3892/ol.2012.810] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
147 Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer. 2010;67:170-176. [PMID: 19446359 DOI: 10.1016/j.lungcan.2009.04.004] [Cited by in Crossref: 209] [Cited by in F6Publishing: 205] [Article Influence: 16.1] [Reference Citation Analysis]
148 Shen K, Hung J, Chang C, Weng Y, Wu M, Chen P. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chemico-Biological Interactions 2017;268:129-35. [DOI: 10.1016/j.cbi.2017.03.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
149 Gao J, Zhang Q, Xu J, Guo L, Li X. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res 2013;25:743-8. [PMID: 24385703 DOI: 10.3978/j.issn.1000-9604.2013.12.04] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
150 Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010;411:846-852. [PMID: 20223231 DOI: 10.1016/j.cca.2010.02.074] [Cited by in Crossref: 367] [Cited by in F6Publishing: 365] [Article Influence: 30.6] [Reference Citation Analysis]
151 Yang Q, Yang F, Dai W, Meng X, Wei W, Cheng Y, Dong J, Lu H, Dong H. DNA Logic Circuits for Multiple Tumor Cells Identification Using Intracellular MicroRNA Molecular Bispecific Recognition. Adv Healthc Mater 2021;10:e2101130. [PMID: 34486246 DOI: 10.1002/adhm.202101130] [Reference Citation Analysis]
152 Abba M, Patil N, Allgayer H. MicroRNAs in the Regulation of MMPs and Metastasis. Cancers (Basel) 2014;6:625-45. [PMID: 24670365 DOI: 10.3390/cancers6020625] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
153 Barh D, Tiwari S, Kumavath RN, Ghosh P, Azevedo V. Linking common non-coding RNAs of human lung cancer and M. tuberculosis. Bioinformation 2018;14:337-45. [PMID: 30237679 DOI: 10.6026/97320630014337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Lee KS, Nam SK, Koh J, Kim DW, Kang SB, Choe G, Kim WH, Lee HS. Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases. J Pathol Transl Med 2016;50:270-7. [PMID: 27240857 DOI: 10.4132/jptm.2016.03.19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
155 Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, Zhu G, Liu Z, Tu Y, Peng G. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012;323:41-47. [PMID: 22469786 DOI: 10.1016/j.canlet.2012.03.029] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
156 Ou H, Li Y, Kang M. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene. PLoS One 2014;9:e109929. [PMID: 25365510 DOI: 10.1371/journal.pone.0109929] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
157 Wang W, Li J, Zhu W, Gao C, Jiang R, Li W, Hu Q, Zhang B. MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis. BMC Cancer 2014;14:819. [PMID: 25376700 DOI: 10.1186/1471-2407-14-819] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
158 Jiang Z, Wang H, Zhang X, Liu C, Li Z. An enzyme-free signal amplification strategy for sensitive detection of microRNA via catalyzed hairpin assembly. Anal Methods 2014;6:9477-82. [DOI: 10.1039/c4ay02142h] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
159 Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W, Liu Z, Huang JA. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo. Oncotarget 2017;8:30817-29. [PMID: 28199217 DOI: 10.18632/oncotarget.10339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
160 Giovannetti E, Toffalorio F, De Pas T, Peters GJ. Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? Pharmacogenomics 2012;13:1073-86. [PMID: 22838953 DOI: 10.2217/pgs.12.91] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
161 Wang Z, Han Z, Zhang L, Zhang S, Wang B. MicroRNA-98-5p regulates the proliferation and apoptosis of A549 cells by targeting MAP4K3. Oncol Lett 2019;18:4288-93. [PMID: 31579095 DOI: 10.3892/ol.2019.10771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
162 Bjaanaes MM, Halvorsen AR, Solberg S, Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M, Pastorino U, Kure E, Børresen-Dale AL, Brustugun OT, Helland A. Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int J Cancer 2014;135:1812-21. [PMID: 24599520 DOI: 10.1002/ijc.28828] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
163 Zhang Q, Yan HH, Ru C, Zhu F, Zou HY, Gao PF, Huang CZ, Wang J. Plasmonic biosensor for the highly sensitive detection of microRNA-21 via the chemical etching of gold nanorods under a dark-field microscope. Biosens Bioelectron 2021;201:113942. [PMID: 34996004 DOI: 10.1016/j.bios.2021.113942] [Reference Citation Analysis]
164 Kuppusamy P, Govindan N, Yusoff MM, Ichwan SJA. Proteins are potent biomarkers to detect colon cancer progression. Saudi J Biol Sci 2017;24:1212-21. [PMID: 28855814 DOI: 10.1016/j.sjbs.2014.09.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
165 He Q, Cai L, Shuai L, Li D, Wang C, Liu Y, Li X, Li Z, Wang S. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21: Ars2 IS OVEREXPRESSED IN HUMAN CHOLANGIOCARCINOMAS. Mol Carcinog 2013;52:286-96. [DOI: 10.1002/mc.21859] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
166 Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K, Wei L, Chu M. The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol. 2013;43:813-820. [PMID: 23817461 DOI: 10.1093/jjco/hyt084] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
167 Ye Q, Putila J, Raese R, Dong C, Qian Y, Dowlati A, Guo NL. Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data. Int J Mol Sci 2021;22:7658. [PMID: 34299277 DOI: 10.3390/ijms22147658] [Reference Citation Analysis]
168 Kim WC, Lee CH. The role of mammalian ribonucleases (RNases) in cancer. Biochim Biophys Acta 2009;1796:99-113. [PMID: 19463900 DOI: 10.1016/j.bbcan.2009.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
169 Giovannetti E, Erozenci A, Smit J, Danesi R, Peters GJ. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Critical Reviews in Oncology/Hematology 2012;81:103-22. [DOI: 10.1016/j.critrevonc.2011.03.010] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 9.3] [Reference Citation Analysis]
170 Yu DL, Ma YL, Yu ZG. Inferring microRNA-disease association by hybrid recommendation algorithm and unbalanced bi-random walk on heterogeneous network. Sci Rep 2019;9:2474. [PMID: 30792474 DOI: 10.1038/s41598-019-39226-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
171 Wang Z, Yang B. Detection, Profiling, and Quantification of miRNA Expression. MicroRNA Expression Detection Methods. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-64. [DOI: 10.1007/978-3-642-04928-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci 2018;75:3539-51. [PMID: 30030592 DOI: 10.1007/s00018-018-2877-x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 20.0] [Reference Citation Analysis]
173 Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58:706-714. [PMID: 23053883 DOI: 10.1007/s10620-012-2395-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
174 Wang XC, Wang W, Zhang ZB, Zhao J, Tan XG, Luo JC. Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat Oncol 2013;8:146. [PMID: 23777591 DOI: 10.1186/1748-717X-8-146] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
175 Kjaer-Frifeldt S, Hansen TF, Nielsen BS, Joergensen S, Lindebjerg J, Soerensen FB, dePont Christensen R, Jakobsen A; Danish Colorectal Cancer Group. The prognostic importance of miR-21 in stage II colon cancer: a population-based study. Br J Cancer. 2012;107:1169-1174. [PMID: 23011541 DOI: 10.1038/bjc.2012.365] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
176 Kalogirou C, Spahn M, Krebs M, Joniau S, Lerut E, Burger M, Scholz CJ, Kneitz S, Riedmiller H, Kneitz B. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. Int J Mol Sci 2013;14:21414-34. [PMID: 24173237 DOI: 10.3390/ijms141121414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
177 Zhang JY, Sun MY, Song NH, Deng ZL, Xue CY, Yang J. Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies. BMJ Open 2015;5:e006244. [PMID: 25613953 DOI: 10.1136/bmjopen-2014-006244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
178 Lee HW, Lee EH, Ha SY, Lee CH, Chang HK, Chang S, Kwon KY, Hwang IS, Roh MS, Seo JW. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. Pathol Int. 2012;62:583-591. [PMID: 22924844 DOI: 10.1111/j.1440-1827.2012.02845.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
179 Kor K, Turner APF, Zarei K, Atabati M, Beni V, Mak WC. Structurally responsive oligonucleotide-based single-probe lateral-flow test for detection of miRNA-21 mimics. Anal Bioanal Chem 2016;408:1475-85. [DOI: 10.1007/s00216-015-9250-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
180 Kong C, Yao YX, Bing ZT, Guo BH, Huang L, Huang ZG, Lai YC. Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer. PLoS Comput Biol 2020;16:e1007793. [PMID: 32428028 DOI: 10.1371/journal.pcbi.1007793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 You W, Wang Y, Zheng J. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. Reprod Sci 2015;22:1037-41. [PMID: 25701838 DOI: 10.1177/1933719115570902] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
182 Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13:39-53. [PMID: 19175699 DOI: 10.1111/j.1582-4934.2008.00556.x] [Cited by in Crossref: 656] [Cited by in F6Publishing: 681] [Article Influence: 50.5] [Reference Citation Analysis]
183 Tang H, Zhu J, Du W, Liu S, Zeng Y, Ding Z, Zhang Y, Wang X, Liu Z, Huang J. CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer. J Exp Clin Cancer Res. 2018;37:131. [PMID: 29970127 DOI: 10.1186/s13046-018-0811-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
184 Stenvold H, Donnem T, Andersen S, Al-Saad S, Valkov A, Pedersen MI, Busund LT, Bremnes RM. High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome. BMC Clin Pathol 2014;14:9. [PMID: 24524655 DOI: 10.1186/1472-6890-14-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
185 Kaina B, Izzotti A, Xu J, Christmann M, Pulliero A, Zhao X, Dobreanu M, Au WW. Inherent and toxicant-provoked reduction in DNA repair capacity: A key mechanism for personalized risk assessment, cancer prevention and intervention, and response to therapy. International Journal of Hygiene and Environmental Health 2018;221:993-1006. [DOI: 10.1016/j.ijheh.2018.07.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
186 Zhou H, Xiao B, Zhou F, Deng H, Zhang X, Lou Y, Gong Z, Du C, Guo J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers. 2012;17:104-110. [PMID: 22263628 DOI: 10.3109/1354750x.2011.614961] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
187 Gallach S, Jantus-Lewintre E, Calabuig-Fariñas S, Montaner D, Alonso S, Sirera R, Blasco A, Usó M, Guijarro R, Martorell M, Camps C. MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value. Oncotarget 2017;8:56143-57. [PMID: 28915579 DOI: 10.18632/oncotarget.18603] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
188 Chen X. miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. Mol BioSyst 2016;12:624-33. [DOI: 10.1039/c5mb00697j] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
189 Shen KH, Hung JH, Liao YC, Tsai ST, Wu MJ, Chen PS. Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs. Int J Mol Sci 2020;21:E3080. [PMID: 32349289 DOI: 10.3390/ijms21093080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
190 Dijkstra JR, Mekenkamp LJ, Teerenstra S, De Krijger I, Nagtegaal ID. MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls. J Cell Mol Med 2012;16:683-90. [PMID: 22003827 DOI: 10.1111/j.1582-4934.2011.01467.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
191 Xu J, Li Z, Li Y, Lu Y, Wang J. Activation of palindromes on a degradable modular grafting probe enables ultrasensitive detection of microRNAs. Chem Commun (Camb) 2021;57:5941-4. [PMID: 34018521 DOI: 10.1039/d1cc01150b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Zaporozhchenko IA, Morozkin ES, Skvortsova TE, Ponomaryova AA, Rykova EY, Cherdyntseva NV, Polovnikov ES, Pashkovskaya OA, Pokushalov EA, Vlassov VV, Laktionov PP. Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer. PLoS One 2016;11:e0165261. [PMID: 27768748 DOI: 10.1371/journal.pone.0165261] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
193 Ferraro A, Kontos CK, Boni T, Bantounas I, Siakouli D, Kosmidou V, Vlassi M, Spyridakis Y, Tsipras I, Zografos G, Pintzas A. Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential. Epigenetics 2014;9:129-41. [PMID: 24149370 DOI: 10.4161/epi.26842] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
194 Jiang L, Huang Q, Chang J, Wang E, Qiu X. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res. 2011;37:387-398. [PMID: 21777146 DOI: 10.3109/01902148.2010.492068] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
195 Zhang Y, Chen Z, Feng L, Jiang P, Li X, Wang X. Ionizing Radiation-inducible microRNA-21 Induces Angiogenesis by Directly Targeting PTEN. Asian Pac J Cancer Prev 2019;20:1587-93. [PMID: 31128066 DOI: 10.31557/APJCP.2019.20.5.1587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
196 Peng W, Lan W, Zhong J, Wang J, Pan Y. A novel method of predicting microRNA-disease associations based on microRNA, disease, gene and environment factor networks. Methods 2017;124:69-77. [DOI: 10.1016/j.ymeth.2017.05.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
197 Izzotti A, Larghero P, Balansky R, Pfeffer U, Steele VE, De Flora S. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat Res 2011;717:17-24. [PMID: 20974155 DOI: 10.1016/j.mrfmmm.2010.10.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
198 Tian T, Xiao H, Zhang X, Peng S, Zhang X, Guo S, Wang S, Liu S, Zhou X, Meyers C, Zhou X. Simultaneously sensitive detection of multiple miRNAs based on a strand displacement amplification. Chem Commun 2013;49:75-7. [DOI: 10.1039/c2cc36728a] [Cited by in Crossref: 37] [Cited by in F6Publishing: 3] [Article Influence: 4.1] [Reference Citation Analysis]
199 Chen X, Liu MX, Yan GY. RWRMDA: predicting novel human microRNA-disease associations. Mol Biosyst 2012;8:2792-8. [PMID: 22875290 DOI: 10.1039/c2mb25180a] [Cited by in Crossref: 272] [Cited by in F6Publishing: 225] [Article Influence: 30.2] [Reference Citation Analysis]
200 Langevin SM, Stone RA, Bunker CH, Lyons-Weiler MA, LaFramboise WA, Kelly L, Seethala RR, Grandis JR, Sobol RW, Taioli E. MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer 2011;117:1454-62. [PMID: 21425146 DOI: 10.1002/cncr.25689] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
201 Michael Traeger M, Rehkaemper J, Ullerich H, Steinestel K, Wardelmann E, Senninger N, Abdallah Dhayat S. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol 2018;144:2419-31. [DOI: 10.1007/s00432-018-2755-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
202 Cherni I, Weiss GJ. miRNAs in lung cancer: large roles for small players. Future Oncol 2011;7:1045-55. [PMID: 21919692 DOI: 10.2217/fon.11.74] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
203 Kesanakurti D, Maddirela DR, Chittivelu S, Rao JS, Chetty C. Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem Biophys Res Commun 2013;434:627-33. [PMID: 23583374 DOI: 10.1016/j.bbrc.2013.03.132] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
204 Liu Q, Kang P, Chen Z, Shi C, Chen Y, Yu R. Highly specific and sensitive detection of microRNAs by tandem signal amplification based on duplex-specific nuclease and strand displacement. Chem Commun 2019;55:14210-3. [DOI: 10.1039/c9cc06790f] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
205 Liu X, Song B, Li S, Wang N, Yang H. Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis. Mol Med Rep 2017;16:1173-9. [PMID: 28586047 DOI: 10.3892/mmr.2017.6705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
206 Szejniuk WM, Robles AI, McCulloch T, Falkmer UGI, Røe OD. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J 2019;19:5-14. [PMID: 30190521 DOI: 10.1038/s41397-018-0029-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
207 Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L, Cerny R. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genetics and Cytogenetics 2010;200:154-60. [DOI: 10.1016/j.cancergencyto.2010.04.015] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
208 Zhang J, Zhang Y, Shen W, Fu R, Ding Z, Zhen Y, Wan Y. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Biomed Pharmacother 2019;117:109058. [PMID: 31176168 DOI: 10.1016/j.biopha.2019.109058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
209 Guz M, Rivero-Müller A, Okoń E, Stenzel-Bembenek A, Polberg K, Słomka M, Stepulak A. MicroRNAs-role in lung cancer. Dis Markers 2014;2014:218169. [PMID: 24744457 DOI: 10.1155/2014/218169] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
210 Gu R, Liu N, Luo S, Huang W, Zha Z, Yang J. MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytes. Medicine (Baltimore) 2016;95:e4315. [PMID: 27603333 DOI: 10.1097/MD.0000000000004315] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 8.4] [Reference Citation Analysis]
211 Xu Q, Ma F, Huang S, Tang B, Zhang C. Nucleic Acid Amplification-Free Bioluminescent Detection of MicroRNAs with High Sensitivity and Accuracy Based on Controlled Target Degradation. Anal Chem 2017;89:7077-83. [DOI: 10.1021/acs.analchem.7b00892] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
212 Leidinger P, Backes C, Dahmke IN, Galata V, Huwer H, Stehle I, Bals R, Keller A, Meese E. What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls. Oncotarget 2014;5:9484-97. [PMID: 25344866 DOI: 10.18632/oncotarget.2419] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
213 Shan X, Zhang H, Zhang L, Zhou X, Wang T, Zhang J, Shu Y, Zhu W, Wen W, Liu P. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China. Cancer Med 2018;7:2370-81. [PMID: 29673101 DOI: 10.1002/cam4.1490] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
214 Wen J, Fu J, Zhang W, Guo M. Genetic and epigenetic changes in lung carcinoma and their clinical implications. Mod Pathol 2011;24:932-43. [DOI: 10.1038/modpathol.2011.46] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
215 Ye R, Wei B, Li S, Liu W, Liu J, Qiu L, Wu X, Zhao Z, Li J. Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer. Oncotarget 2017;8:97260-72. [PMID: 29228608 DOI: 10.18632/oncotarget.21919] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
216 Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. Biomarkers for smoking cessation. Clin Pharmacol Ther 2013;93:526-38. [PMID: 23588313 DOI: 10.1038/clpt.2013.57] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
217 Yu H, Pang Z, Li G, Gu T. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. J Clin Lab Anal 2021;35:e23588. [PMID: 32965722 DOI: 10.1002/jcla.23588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Dong L, Luo M, Wang F, Zhang J, Li T, Yu J. TUMIR: an experimentally supported database of microRNA deregulation in various cancers. J Clin Bioinforma 2013;3:7. [PMID: 23594715 DOI: 10.1186/2043-9113-3-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
219 Sana J, Faltejskova P, Svoboda M, Slaby O. Novel classes of non-coding RNAs and cancer. J Transl Med. 2012;10:103. [PMID: 22613733 DOI: 10.1186/1479-5876-10-103] [Cited by in Crossref: 179] [Cited by in F6Publishing: 165] [Article Influence: 17.9] [Reference Citation Analysis]
220 Cao H, Zhou X, Zeng Y. Microfluidic Exponential Rolling Circle Amplification for Sensitive microRNA Detection Directly from Biological Samples. Sens Actuators B Chem 2019;279:447-57. [PMID: 30533973 DOI: 10.1016/j.snb.2018.09.121] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
221 Markou A, Liang Y, Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 2011;49:1591-603. [PMID: 21767219 DOI: 10.1515/CCLM.2011.661] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
222 Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, Harris AL. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010;116:2148-58. [PMID: 20187102 DOI: 10.1002/cncr.25009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 107] [Article Influence: 2.7] [Reference Citation Analysis]
223 Detassis S, Grasso M, Del Vescovo V, Denti MA. microRNAs Make the Call in Cancer Personalized Medicine. Front Cell Dev Biol 2017;5:86. [PMID: 29018797 DOI: 10.3389/fcell.2017.00086] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
224 Liu R, Zhang S, Zheng TT, Chen YR, Wu JT, Wu ZS. Intracellular Nonenzymatic In Situ Growth of Three-Dimensional DNA Nanostructures for Imaging Specific Biomolecules in Living Cells. ACS Nano 2020;14:9572-84. [PMID: 32806042 DOI: 10.1021/acsnano.9b09995] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
225 Cui F, Qiu Q, Peng G, Li X, Liu X, Chen X. Core–shell CdSeTe/ZnS quantum dots for the detection of microRNA-155 based on the fluorescence resonance energy transfer technique via the formation of a network structure. Anal Methods 2019;11:4137-45. [DOI: 10.1039/c9ay00783k] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
226 Toland AE. Aberrant Epigenetic Regulation in Breast Cancer. In: Minarovits J, Niller HH, editors. Patho-Epigenetics of Disease. New York: Springer; 2012. pp. 91-122. [DOI: 10.1007/978-1-4614-3345-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
227 Khan SY, Tariq MA, Perrott JP, Brumbaugh CD, Kim HJ, Shabbir MI, Ramesh GT, Pourmand N. Distinctive microRNA expression signatures in proton-irradiated mice. Mol Cell Biochem 2013;382:225-35. [PMID: 23817773 DOI: 10.1007/s11010-013-1738-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
228 Alipoor SD, Adcock IM, Garssen J, Mortaz E, Varahram M, Mirsaeidi M, Velayati A. The roles of miRNAs as potential biomarkers in lung diseases. Eur J Pharmacol 2016;791:395-404. [PMID: 27634639 DOI: 10.1016/j.ejphar.2016.09.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 12.8] [Reference Citation Analysis]
229 Wang X, Zhang Y, Zhi X. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study. Thorac Cancer 2017;8:511-6. [PMID: 28727276 DOI: 10.1111/1759-7714.12480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
230 Wang M, Moisá S, Khan MJ, Wang J, Bu D, Loor JJ. MicroRNA expression patterns in the bovine mammary gland are affected by stage of lactation. J Dairy Sci 2012;95:6529-35. [PMID: 22959945 DOI: 10.3168/jds.2012-5748] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
231 Larzabal L, de Aberasturi AL, Redrado M, Rueda P, Rodriguez MJ, Bodegas ME, Montuenga LM, Calvo A. TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. Br J Cancer 2014;110:764-74. [PMID: 24434435 DOI: 10.1038/bjc.2013.761] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
232 Boldrini L, Giordano M, Servadio A, Niccoli C, Bertoglio P, Lucchi M, Melfi F, Mussi A, Fontanini G. Prognostic role of TPL2 in early‑stage non‑small cell lung cancer. Mol Med Rep 2017;15:3451-8. [PMID: 28393206 DOI: 10.3892/mmr.2017.6430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
233 Zhang Y, Lu H, Xu G. [Effect of PI3K/AKT pathway on cisplatin resistance in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2014;17:635-42. [PMID: 25130971 DOI: 10.3779/j.issn.1009-3419.2014.08.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
234 Yang Z, Fang S, Di Y, Ying W, Tan Y, Gu W. Modulation of NF-κB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin. PLoS One 2015;10:e0121547. [PMID: 25799148 DOI: 10.1371/journal.pone.0121547] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
235 Rasti A, Mehrazma M, Madjd Z, Keshtkar AA, Roudi R, Babashah S. Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol. BMJ Open 2016;6:e009667. [PMID: 26729387 DOI: 10.1136/bmjopen-2015-009667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
236 Bao G, Sun J, Zheng H, Hou J, Huang J, Wei J, Fu Y, Qiu J, Zou X, Xiang B, Cai J. Visualization of microRNA-21 Dynamics in Neuroblastoma Using Magnetic Resonance Imaging Based on a microRNA-21-Responsive Reporter Gene. Front Oncol 2021;11:747305. [PMID: 34804934 DOI: 10.3389/fonc.2021.747305] [Reference Citation Analysis]
237 Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D, Huang JA, Liu Z. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer 2017;16:34. [PMID: 28158983 DOI: 10.1186/s12943-017-0591-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
238 Gao W, Xu J, Shu YQ. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Expert Rev Respir Med 2011;5:699-709. [PMID: 21955239 DOI: 10.1586/ers.11.55] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
239 Yin W, Zhao Y, Ji YJ, Tong LP, Liu Y, He SX, Wang AQ. Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China. Biomed Res Int. 2015;2015:965185. [PMID: 25688372 DOI: 10.1155/2015/965185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
240 Mugunga I, Ju Y, Liu X, Huang X. Computational prediction of human disease-related microRNAs by path-based random walk. Oncotarget 2017;8:58526-35. [PMID: 28938576 DOI: 10.18632/oncotarget.17226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
241 Lin L, Zhang Y, Wei Q, Lin H, Li X, Yu ME, Wang J, Huang Z, Xue D. Structure and function encoding of a bidirectional activatable synergetic DNA machine for speeded and ultrasensitive determination of microRNAs. Talanta 2022;238:123037. [PMID: 34857317 DOI: 10.1016/j.talanta.2021.123037] [Reference Citation Analysis]
242 Di Leva G, Briskin D, Croce CM. MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci 2012;117:202-16. [PMID: 22348396 DOI: 10.3109/03009734.2012.660551] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
243 Fredj Z, Azzouzi S, Turner AP, Ali MB, Mak WC. Neutravidin biosensor for direct capture of dual-functional biotin-molecular beacon-AuNP probe for sensitive voltammetric detection of microRNA. Sensors and Actuators B: Chemical 2017;248:77-84. [DOI: 10.1016/j.snb.2017.03.160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
244 Alečković M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 2015;1855:24-42. [PMID: 25450578 DOI: 10.1016/j.bbcan.2014.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
245 Zhang W, Wei L, Luo R, Liu H, Chen J. The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21483. [PMID: 32871993 DOI: 10.1097/MD.0000000000021483] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
246 Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res. 2010;16:430-441. [PMID: 20068076 DOI: 10.1158/1078-0432.ccr-09-1736] [Cited by in Crossref: 231] [Cited by in F6Publishing: 143] [Article Influence: 19.3] [Reference Citation Analysis]
247 Falcon-perez JM, Royo F. Circulating RNA: looking at the liver through a frosted glass. Biomarkers 2015;20:339-54. [DOI: 10.3109/1354750x.2015.1101785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Wang X, Tian L, Jiang X, Wang Y, Li D, She Y, Chang J, Meng A. The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Letters 2011;311:203-9. [DOI: 10.1016/j.canlet.2011.07.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
249 Cho WC. Role of miRNAs in lung cancer. Expert Review of Molecular Diagnostics 2014;9:773-6. [DOI: 10.1586/erm.09.57] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
250 Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009;15:1443-61. [PMID: 19561119 DOI: 10.1261/rna.1534709] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 9.2] [Reference Citation Analysis]
251 Lin LF, Li YT, Han H, Lin SG. MicroRNA-205-5p targets the HOXD9-Snail1 axis to inhibit triple negative breast cancer cell proliferation and chemoresistance. Aging (Albany NY) 2021;13:3945-56. [PMID: 33428601 DOI: 10.18632/aging.202363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys. 2013;67:875-884. [PMID: 23559272 DOI: 10.1007/s12013-013-9575-y] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 13.6] [Reference Citation Analysis]
253 Markou A, Zavridou M, Lianidou ES. miRNA-21 as a novel therapeutic target in lung cancer. Lung Cancer (Auckl) 2016;7:19-27. [PMID: 28210157 DOI: 10.2147/LCTT.S60341] [Cited by in Crossref: 11] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
254 Bi N, Cao J, Song Y, Shen J, Liu W, Fan J, He J, Shi Y, Zhang X, Lu N, Zhan Q, Wang L. A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy. PLoS One 2014;9:e91388. [PMID: 24637927 DOI: 10.1371/journal.pone.0091388] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
255 Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18:282-293. [PMID: 20832755 DOI: 10.1016/j.ccr.2010.08.013] [Cited by in Crossref: 408] [Cited by in F6Publishing: 418] [Article Influence: 34.0] [Reference Citation Analysis]
256 Liu H, Bei X, Xia Q, Fu Y, Zhang S, Liu M, Fan K, Zhang M, Yang Y. Enzyme-free electrochemical detection of microRNA-21 using immobilized hairpin probes and a target-triggered hybridization chain reaction amplification strategy. Microchim Acta 2016;183:297-304. [DOI: 10.1007/s00604-015-1636-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
257 Chen C, Tang J, Xu S, Zhang W, Jiang H. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Biomed Res Int 2020;2020:2547902. [PMID: 32351986 DOI: 10.1155/2020/2547902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
258 Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med (Maywood) 2014;239:1505-13. [PMID: 24872439 DOI: 10.1177/1535370214533887] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
259 Tian F, Shen Y, Chen Z, Li R, Lu J, Ge Q. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Gene 2016;591:338-43. [DOI: 10.1016/j.gene.2016.06.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
260 Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, Li P, Cai H, Yu L, Liu F, Hang D, Yang H, Wang XW, Ke Y, Harris CC. microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer 2013;132:2901-9. [PMID: 23175214 DOI: 10.1002/ijc.27954] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
261 Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, Bello AM, De Luca P, Calabrese C, Fusco A, Ceccarelli M, Zollo M, Barbacid M, Di Lauro R, De Vita G. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 2011;30:275-86. [PMID: 20956945 DOI: 10.1038/onc.2010.416] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 8.1] [Reference Citation Analysis]
262 Cortés-Sempere M, Ibáñez de Cáceres I. microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol 2011;13:357-62. [PMID: 21680295 DOI: 10.1007/s12094-011-0668-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
263 Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer. 2010;10:318. [PMID: 20569443 DOI: 10.1186/1471-2407-10-318] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 12.3] [Reference Citation Analysis]
264 Chen X, Xie D, Zhao Q, You ZH. MicroRNAs and complex diseases: from experimental results to computational models. Brief Bioinform 2019;20:515-39. [PMID: 29045685 DOI: 10.1093/bib/bbx130] [Cited by in Crossref: 219] [Cited by in F6Publishing: 208] [Article Influence: 73.0] [Reference Citation Analysis]
265 Du Y, Liu Z, Gu L, Zhou J, Zhu BD, Ji J, Deng D. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo. BMC Cancer. 2012;12:249. [PMID: 22703336 DOI: 10.1186/1471-2407-12-249] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
266 Ye Z, Sun B, Xiao Z. Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma. Gene 2020;749:144669. [PMID: 32298761 DOI: 10.1016/j.gene.2020.144669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
267 Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009;45:2197-206. [PMID: 19493678 DOI: 10.1016/j.ejca.2009.04.039] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 12.2] [Reference Citation Analysis]
268 Wang Y, Shi J, Wu Y, Xu W, Wang Q, Zhang J, Jiang M, Gu G. Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application. Tumori 2012;98:792-9. [DOI: 10.1177/030089161209800618] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
269 Nielsen BS, Jørgensen S, Fog JU, Søkilde R, Christensen IJ, Hansen U, Brünner N, Baker A, Møller S, Nielsen HJ. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2011;28:27-38. [PMID: 21069438 DOI: 10.1007/s10585-010-9355-7] [Cited by in Crossref: 199] [Cited by in F6Publishing: 200] [Article Influence: 16.6] [Reference Citation Analysis]
270 Zhao YL, Zhang JX, Yang JJ, Wei YB, Peng JF, Fu CJ, Huang MH, Wang R, Wang PY, Sun GB, Xie SY. MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer. Thorac Cancer 2022. [PMID: 35076182 DOI: 10.1111/1759-7714.14331] [Reference Citation Analysis]
271 Xiao H, Xue Q, Zhang Q, Li C, Liu X, Liu J, Li H, Yang J. How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma Cells. Am J Chin Med 2019;47:1737-54. [PMID: 31795742 DOI: 10.1142/S0192415X19500885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
272 Wang Y, Zhang Y, Pan C, Ma F, Zhang S. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One 2015;10:e0118647. [PMID: 25706383 DOI: 10.1371/journal.pone.0118647] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
273 Han Li C, Chen Y. Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. Curr Genomics 2015;16:319-26. [PMID: 27047252 DOI: 10.2174/1389202916666150707155851] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
274 Bowden M, Zhou CW, Zhang S, Brais L, Rossi A, Naudin L, Thiagalingam A, Sicinska E, Kulke MH. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma. Oncotarget 2017;8:54331-44. [PMID: 28903345 DOI: 10.18632/oncotarget.16908] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
275 Bhere D, Arghiani N, Lechtich ER, Yao Y, Alsaab S, Bei F, Matin MM, Shah K. Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy. Sci Rep 2020;10:1779. [PMID: 32019988 DOI: 10.1038/s41598-020-58072-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
276 Wei J, Liu B, Cardona AF, Rosell R. Molecular biomarkers for predicting chemotherapy response in lung cancer. Expert Opin Med Diagn 2009;3:621-9. [PMID: 23496047 DOI: 10.1517/17530050903222239] [Reference Citation Analysis]
277 Chen WS, Hou JN, Guo YB, Yang HL, Xie CM, Lin YC, She ZG. Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. J Exp Clin Cancer Res 2011;30:17. [PMID: 21303527 DOI: 10.1186/1756-9966-30-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
278 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
279 Świtlik W, Karbownik MS, Suwalski M, Kozak J, Szemraj J. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study. Cancer Biomark 2018;21:479-88. [PMID: 29103030 DOI: 10.3233/CBM-170767] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
280 Li W, Cui Y, Wang D, Wang Y, Wang L. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer. Biochemical and Biophysical Research Communications 2019;509:647-56. [DOI: 10.1016/j.bbrc.2018.12.089] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
281 Ebrahimi A, Sadroddiny E. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications. Pulm Pharmacol Ther 2015;34:55-63. [PMID: 26319446 DOI: 10.1016/j.pupt.2015.08.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
282 Qiao W, Zhang T, Yen T, Ku TH, Song J, Lian I, Lo YH. Oil-encapsulated nanodroplet array for bio-molecular detection. Ann Biomed Eng 2014;42:1932-41. [PMID: 24866572 DOI: 10.1007/s10439-014-1039-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
283 Wang XC, Tian LL, Wu HL, Jiang XY, Du LQ, Zhang H, Wang YY, Wu HY, Li DG, She Y, Liu QF, Fan FY, Meng AM. Expression of miRNA-130a in nonsmall cell lung cancer. Am J Med Sci 2010;340:385-8. [PMID: 20625274 DOI: 10.1097/MAJ.0b013e3181e892a0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
284 Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev 2015;44:2963-97. [DOI: 10.1039/c4cs00370e] [Cited by in Crossref: 535] [Cited by in F6Publishing: 110] [Article Influence: 76.4] [Reference Citation Analysis]
285 Mairinger FD, Ting S, Werner R, Walter RF, Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T, Sheu-Grabellus SY, Theegarten D, Schmid KW, Wohlschlaeger J. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study. Mod Pathol 2014;27:1632-40. [PMID: 24875640 DOI: 10.1038/modpathol.2014.74] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
286 Bover I, Rolfo C, Jantus-Lewintre E, Sirera R, Camps C, Chaib I, Ramirez-Serrano JL, Benlloch S, Molina-Vila MA, Simonetti S, Costa C, Gimenez-Capitan A, Mendez P, Taron M, Rosell R. Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop. Lung Cancer 2011;74:535-43. [PMID: 21616552 DOI: 10.1016/j.lungcan.2011.04.016] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
287 Zhong XZ, Deng Y, Chen G, Yang H. Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation. Oncol Lett 2019;17:230-46. [PMID: 30655760 DOI: 10.3892/ol.2018.9627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
288 Kang WK, Lee JK, Oh ST, Lee SH, Jung CK. Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse. BMC Gastroenterol 2015;15:2. [PMID: 25609245 DOI: 10.1186/s12876-015-0227-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
289 Lamichhane SR, Thachil T, De Ieso P, Gee H, Moss SA, Milic N. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Dis Markers 2018;2018:8309015. [PMID: 30538784 DOI: 10.1155/2018/8309015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
290 Kang SM, Lee HJ, Cho JY. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. Cancer Lett 2013;335:487-94. [PMID: 23507558 DOI: 10.1016/j.canlet.2013.03.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
291 Wei J, He S, Mao Y, Wu L, Liu X, Effah CY, Guo H, Wu Y. A simple "signal off-on" fluorescence nanoplatform for the label-free quantification of exosome-derived microRNA-21 in lung cancer plasma. Mikrochim Acta 2021;188:397. [PMID: 34716495 DOI: 10.1007/s00604-021-05051-1] [Reference Citation Analysis]
292 Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat. 2009;117:131-140. [PMID: 18932017 DOI: 10.1007/s10549-008-0219-7] [Cited by in Crossref: 182] [Cited by in F6Publishing: 177] [Article Influence: 13.0] [Reference Citation Analysis]
293 Li JH, Sun SS, Li N, Lv P, Xie SY, Wang PY. MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer. Oncotarget 2017;8:91938-49. [PMID: 29190887 DOI: 10.18632/oncotarget.20262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
294 Yuan J, Chen L, Chen X, Sun W, Zhou X. Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma. J Int Med Res 2012;40:2090-7. [DOI: 10.1177/030006051204000606] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
295 Lu S, Chen L, Tang L. Upregulation of AKT1 and downregulation of AKT3 caused by dysregulation of microRNAs contributes to pathogenesis of hemangioma by promoting proliferation of endothelial cells. J Cell Physiol 2019;234:21342-51. [PMID: 31074018 DOI: 10.1002/jcp.28741] [Reference Citation Analysis]
296 Yang YL, Xu LP, Zhuo FL, Wang TY. Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients. Tumour Biol 2015;36:7069-75. [PMID: 25869877 DOI: 10.1007/s13277-015-3366-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
297 Wang J, Li S, Xu J, Lu Y, Lin M, Wang C, Zhang C, Lin G, Jia L. A functionalized dumbbell probe-based cascading exponential amplification DNA machine enables amplified probing of microRNAs. Chem Commun (Camb) 2020;56:1681-4. [PMID: 31939961 DOI: 10.1039/c9cc08289a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
298 Liao B, Ding S, Chen H, Li Z, Cai L. Identifying human microRNA–disease associations by a new diffusion-based method. J Bioinform Comput Biol 2015;13:1550014. [DOI: 10.1142/s0219720015500146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]